THOMAS F ACKERMAN Insider Trading $CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for THOMAS F ACKERMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of THOMAS F ACKERMAN. THOMAS F ACKERMAN is Corp. Executive VP & CFO in CHARLES RIVER LABORATORIES INTERNATIONAL INC ($CRL) and Corp. Sr. VP & CFO in CHARLES RIVER LABORATORIES INTERNATIONAL INC ($CRL) and Senior VP & CFO in CHARLES RIVER LABORATORIES INTERNATIONAL INC ($CRL) and Sr. Vp and CFO in CHARLES RIVER LABORATORIES INTERNATIONAL INC ($CRL).
THOMAS F ACKERMAN in CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Trading Symbol: CRLIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of THOMAS F ACKERMAN: Corp. Executive VP & CFO, Corp. Sr. VP & CFO, Senior VP & CFO, Sr. Vp and CFO
Holdings: 104,211 shares
Current Value: $8,605,744
Latest Transaction: Feb 18 2015
$CRL Market Capitalization: $3.90B
$CRL Previous Close: $82.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of THOMAS F ACKERMAN in CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.01 | 2,500 | 115,025 | 120,273 | 122.8 K to 120.3 K (-2.04 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.01 | 116 | 5,337 | 122,773 | 122.9 K to 122.8 K (-0.09 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.01 | 100 | 4,601 | 122,889 | 123 K to 122.9 K (-0.08 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 46.00 | 8,300 | 381,800 | 122,989 | 131.3 K to 123 K (-6.32 %) |
Aug 06 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Buy | M | 38.03 | 26,250 | 998,288 | 131,289 | 105 K to 131.3 K (+24.99 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 43.09 | 100 | 4,309 | 105,039 | 105.1 K to 105 K (-0.10 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.88 | 100 | 4,288 | 105,139 | 105.2 K to 105.1 K (-0.10 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.80 | 100 | 4,280 | 105,239 | 105.3 K to 105.2 K (-0.09 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.78 | 200 | 8,556 | 105,339 | 105.5 K to 105.3 K (-0.19 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.73 | 100 | 4,273 | 105,539 | 105.6 K to 105.5 K (-0.09 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.60 | 100 | 4,260 | 105,639 | 105.7 K to 105.6 K (-0.09 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.59 | 100 | 4,259 | 105,739 | 105.8 K to 105.7 K (-0.09 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.51 | 100 | 4,251 | 105,839 | 105.9 K to 105.8 K (-0.09 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.44 | 100 | 4,244 | 105,939 | 106 K to 105.9 K (-0.09 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.40 | 200 | 8,480 | 106,039 | 106.2 K to 106 K (-0.19 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.38 | 100 | 4,238 | 106,239 | 106.3 K to 106.2 K (-0.09 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.36 | 200 | 8,472 | 106,339 | 106.5 K to 106.3 K (-0.19 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.35 | 100 | 4,235 | 106,539 | 106.6 K to 106.5 K (-0.09 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.34 | 100 | 4,234 | 106,639 | 106.7 K to 106.6 K (-0.09 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.33 | 200 | 8,466 | 106,739 | 106.9 K to 106.7 K (-0.19 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.32 | 100 | 4,232 | 106,939 | 107 K to 106.9 K (-0.09 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.31 | 600 | 25,386 | 107,039 | 107.6 K to 107 K (-0.56 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.30 | 300 | 12,690 | 107,639 | 107.9 K to 107.6 K (-0.28 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.28 | 100 | 4,228 | 107,939 | 108 K to 107.9 K (-0.09 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.27 | 300 | 12,681 | 108,039 | 108.3 K to 108 K (-0.28 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.26 | 200 | 8,452 | 108,339 | 108.5 K to 108.3 K (-0.18 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.25 | 100 | 4,225 | 108,539 | 108.6 K to 108.5 K (-0.09 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.22 | 100 | 4,222 | 108,639 | 108.7 K to 108.6 K (-0.09 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.21 | 100 | 4,221 | 108,739 | 108.8 K to 108.7 K (-0.09 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.20 | 100 | 4,220 | 108,839 | 108.9 K to 108.8 K (-0.09 %) |
Jun 05 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 42.08 | 100 | 4,208 | 108,939 | 109 K to 108.9 K (-0.09 %) |
Feb 27 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 39.61 | 1,537 | 60,881 | 109,039 | 110.6 K to 109 K (-1.39 %) |
Feb 27 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 39.76 | 1,137 | 45,207 | 110,576 | 111.7 K to 110.6 K (-1.02 %) |
Feb 26 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | A | 40.00 | 17,423 | 696,920 | 17,423 | |
Feb 26 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 40.40 | 2,625 | 106,050 | 111,713 | 114.3 K to 111.7 K (-2.30 %) |
Feb 26 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Grant | A | 0.00 | 5,451 | 0 | 114,338 | 108.9 K to 114.3 K (+5.01 %) |
Jan 08 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | M | 32.87 | 26,600 | 874,342 | 0 | |
Jan 08 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 39.00 | 30,600 | 1,193,400 | 108,887 | 139.5 K to 108.9 K (-21.94 %) |
Jan 08 2013 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Buy | M | 32.87 | 26,600 | 874,342 | 139,487 | 112.9 K to 139.5 K (+23.56 %) |
Oct 03 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 40.00 | 8,000 | 320,000 | 112,887 | 120.9 K to 112.9 K (-6.62 %) |
Oct 03 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Gift | G | 0.00 | 1,000 | 0 | 120,887 | 121.9 K to 120.9 K (-0.82 %) |
Jul 12 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | M | 32.15 | 11,700 | 376,155 | 0 | |
Jul 12 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 32.32 | 100 | 3,232 | 121,887 | 122 K to 121.9 K (-0.08 %) |
Jul 12 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 32.31 | 100 | 3,231 | 121,987 | 122.1 K to 122 K (-0.08 %) |
Jul 12 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 32.33 | 300 | 9,699 | 110,387 | 110.7 K to 110.4 K (-0.27 %) |
Jul 12 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 32.32 | 296 | 9,567 | 110,687 | 111 K to 110.7 K (-0.27 %) |
Jul 12 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 32.31 | 604 | 19,515 | 110,983 | 111.6 K to 111 K (-0.54 %) |
Jul 12 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 32.30 | 10,300 | 332,690 | 111,587 | 121.9 K to 111.6 K (-8.45 %) |
Jul 12 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Buy | M | 32.15 | 11,700 | 376,155 | 122,087 | 110.4 K to 122.1 K (+10.60 %) |
Jul 05 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | M | 32.15 | 11,500 | 369,725 | 11,700 | |
Jul 05 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 34.00 | 11,500 | 391,000 | 121,887 | 133.4 K to 121.9 K (-8.62 %) |
Jul 05 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Buy | M | 32.15 | 11,500 | 369,725 | 133,387 | 121.9 K to 133.4 K (+9.43 %) |
Jun 22 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | M | 32.15 | 200 | 6,430 | 23,200 | |
Jun 22 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Buy | M | 32.15 | 200 | 6,430 | 122,087 | 121.9 K to 122.1 K (+0.16 %) |
Jun 22 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 34.00 | 200 | 6,800 | 121,887 | 122.1 K to 121.9 K (-0.16 %) |
Mar 01 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 35.77 | 727 | 26,005 | 121,887 | 122.6 K to 121.9 K (-0.59 %) |
Feb 28 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | A | 36.25 | 22,150 | 802,938 | 22,150 | |
Feb 28 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 36.25 | 1,370 | 49,663 | 122,614 | 124 K to 122.6 K (-1.10 %) |
Feb 28 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 36.25 | 1,108 | 40,165 | 123,984 | 125.1 K to 124 K (-0.89 %) |
Feb 28 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 36.25 | 953 | 34,546 | 125,092 | 126 K to 125.1 K (-0.76 %) |
Feb 28 2012 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Grant | A | 0.00 | 20,200 | 0 | 126,045 | 105.8 K to 126 K (+19.08 %) |
Apr 06 2011 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | M | 31.97 | 2,757 | 88,141 | 0 | |
Apr 06 2011 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 40.00 | 2,757 | 110,280 | 106,845 | 109.6 K to 106.8 K (-2.52 %) |
Apr 06 2011 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Buy | M | 31.97 | 2,757 | 88,141 | 109,602 | 106.8 K to 109.6 K (+2.58 %) |
Mar 01 2011 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | A | 37.03 | 39,500 | 1,462,685 | 39,500 | |
Mar 01 2011 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 37.03 | 727 | 26,921 | 106,845 | 107.6 K to 106.8 K (-0.68 %) |
Mar 01 2011 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 37.03 | 1,370 | 50,731 | 107,572 | 108.9 K to 107.6 K (-1.26 %) |
Mar 01 2011 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 37.03 | 1,108 | 41,029 | 108,942 | 110.1 K to 108.9 K (-1.01 %) |
Mar 01 2011 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Grant | A | 0.00 | 12,000 | 0 | 110,050 | 98.1 K to 110.1 K (+12.24 %) |
Feb 24 2011 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 36.33 | 886 | 32,188 | 98,050 | 98.9 K to 98.1 K (-0.90 %) |
Aug 12 2010 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 30.47 | 886 | 26,996 | 99,986 | 100.9 K to 100 K (-0.88 %) |
Mar 02 2010 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | A | 37.92 | 50,000 | 1,896,000 | 50,000 | |
Mar 02 2010 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 37.92 | 981 | 37,200 | 100,872 | 101.9 K to 100.9 K (-0.96 %) |
Mar 02 2010 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 37.92 | 727 | 27,568 | 101,853 | 102.6 K to 101.9 K (-0.71 %) |
Mar 02 2010 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 37.92 | 1,370 | 51,950 | 102,580 | 104 K to 102.6 K (-1.32 %) |
Mar 02 2010 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Grant | A | 0.00 | 13,950 | 0 | 103,950 | 90 K to 104 K (+15.50 %) |
Feb 25 2010 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 37.11 | 885 | 32,842 | 90,000 | 90.9 K to 90 K (-0.97 %) |
Aug 12 2009 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 32.71 | 885 | 28,948 | 90,885 | 91.8 K to 90.9 K (-0.96 %) |
Mar 03 2009 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | A | 24.80 | 68,150 | 1,690,120 | 68,150 | |
Mar 03 2009 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 24.80 | 981 | 24,329 | 91,770 | 92.8 K to 91.8 K (-1.06 %) |
Mar 03 2009 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 24.80 | 727 | 18,030 | 92,751 | 93.5 K to 92.8 K (-0.78 %) |
Mar 03 2009 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 24.80 | 877 | 21,750 | 93,478 | 94.4 K to 93.5 K (-0.93 %) |
Mar 03 2009 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Grant | A | 0.00 | 6,177 | 0 | 94,355 | 88.2 K to 94.4 K (+7.01 %) |
Mar 03 2009 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Grant | A | 0.00 | 17,250 | 0 | 88,178 | 70.9 K to 88.2 K (+24.32 %) |
Feb 24 2009 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 26.30 | 886 | 23,302 | 70,928 | 71.8 K to 70.9 K (-1.23 %) |
Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.25 | 162 | 10,895 | 71,814 | 72 K to 71.8 K (-0.23 %) |
Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.79 | 125 | 8,474 | 71,976 | 72.1 K to 72 K (-0.17 %) |
Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.70 | 50 | 3,385 | 72,101 | 72.2 K to 72.1 K (-0.07 %) |
Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.53 | 112 | 7,563 | 72,151 | 72.3 K to 72.2 K (-0.15 %) |
Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.50 | 150 | 10,125 | 72,263 | 72.4 K to 72.3 K (-0.21 %) |
Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.48 | 50 | 3,374 | 72,413 | 72.5 K to 72.4 K (-0.07 %) |
Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.30 | 163 | 10,970 | 72,463 | 72.6 K to 72.5 K (-0.22 %) |
Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.85 | 62 | 4,207 | 72,626 | 72.7 K to 72.6 K (-0.09 %) |
Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.84 | 100 | 6,784 | 72,688 | 72.8 K to 72.7 K (-0.14 %) |
Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.77 | 163 | 11,046 | 72,788 | 73 K to 72.8 K (-0.22 %) |
Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.74 | 162 | 10,974 | 72,951 | 73.1 K to 73 K (-0.22 %) |
Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.69 | 163 | 11,033 | 73,113 | 73.3 K to 73.1 K (-0.22 %) |
Aug 15 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 67.66 | 162 | 10,961 | 73,276 | 73.4 K to 73.3 K (-0.22 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | M | 31.97 | 7,500 | 239,775 | 2,757 | |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.70 | 1,000 | 65,700 | 73,438 | 74.4 K to 73.4 K (-1.34 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 66.28 | 500 | 33,140 | 74,438 | 74.9 K to 74.4 K (-0.67 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 66.28 | 250 | 16,570 | 74,938 | 75.2 K to 74.9 K (-0.33 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 66.13 | 250 | 16,531 | 75,188 | 75.4 K to 75.2 K (-0.33 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 66.12 | 500 | 33,060 | 75,438 | 75.9 K to 75.4 K (-0.66 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.98 | 100 | 6,598 | 75,938 | 76 K to 75.9 K (-0.13 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.96 | 450 | 29,682 | 76,038 | 76.5 K to 76 K (-0.59 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.70 | 1,000 | 65,700 | 76,488 | 77.5 K to 76.5 K (-1.29 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 66.40 | 750 | 49,800 | 77,488 | 78.2 K to 77.5 K (-0.96 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 66.35 | 367 | 24,350 | 78,238 | 78.6 K to 78.2 K (-0.47 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 66.31 | 183 | 12,135 | 78,605 | 78.8 K to 78.6 K (-0.23 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 66.31 | 200 | 13,262 | 78,788 | 79 K to 78.8 K (-0.25 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 66.27 | 100 | 6,627 | 78,988 | 79.1 K to 79 K (-0.13 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 66.26 | 600 | 39,756 | 79,088 | 79.7 K to 79.1 K (-0.75 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 66.25 | 800 | 53,000 | 79,688 | 80.5 K to 79.7 K (-0.99 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 66.00 | 450 | 29,700 | 80,488 | 80.9 K to 80.5 K (-0.56 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Buy | M | 31.97 | 7,500 | 239,775 | 80,938 | 73.4 K to 80.9 K (+10.21 %) |
Aug 13 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Payment of Exercise | F | 66.05 | 1,164 | 76,882 | 73,438 | 74.6 K to 73.4 K (-1.56 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | M | 31.97 | 2,500 | 79,925 | 10,257 | |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.40 | 250 | 16,350 | 74,602 | 74.9 K to 74.6 K (-0.33 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.14 | 100 | 6,514 | 74,852 | 75 K to 74.9 K (-0.13 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.14 | 100 | 6,514 | 74,952 | 75.1 K to 75 K (-0.13 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.10 | 200 | 13,020 | 75,052 | 75.3 K to 75.1 K (-0.27 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.08 | 200 | 13,016 | 75,252 | 75.5 K to 75.3 K (-0.27 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.04 | 100 | 6,504 | 75,452 | 75.6 K to 75.5 K (-0.13 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.04 | 100 | 6,504 | 75,552 | 75.7 K to 75.6 K (-0.13 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.01 | 300 | 19,503 | 75,652 | 76 K to 75.7 K (-0.39 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.01 | 200 | 13,002 | 75,952 | 76.2 K to 76 K (-0.26 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.01 | 125 | 8,126 | 76,152 | 76.3 K to 76.2 K (-0.16 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.00 | 825 | 53,625 | 76,277 | 77.1 K to 76.3 K (-1.07 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Buy | M | 31.97 | 2,500 | 79,925 | 77,102 | 74.6 K to 77.1 K (+3.35 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | M | 31.97 | 5,000 | 159,850 | 12,757 | |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.40 | 500 | 32,700 | 74,602 | 75.1 K to 74.6 K (-0.67 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 65.07 | 500 | 32,535 | 75,102 | 75.6 K to 75.1 K (-0.66 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 64.87 | 100 | 6,487 | 75,602 | 75.7 K to 75.6 K (-0.13 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 64.86 | 100 | 6,486 | 75,702 | 75.8 K to 75.7 K (-0.13 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 64.85 | 300 | 19,455 | 75,802 | 76.1 K to 75.8 K (-0.39 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 64.66 | 100 | 6,466 | 76,102 | 76.2 K to 76.1 K (-0.13 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 64.66 | 400 | 25,864 | 76,202 | 76.6 K to 76.2 K (-0.52 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 64.62 | 100 | 6,462 | 76,602 | 76.7 K to 76.6 K (-0.13 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 64.60 | 400 | 25,840 | 76,702 | 77.1 K to 76.7 K (-0.52 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 64.58 | 500 | 32,290 | 77,102 | 77.6 K to 77.1 K (-0.64 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 64.50 | 500 | 32,250 | 77,602 | 78.1 K to 77.6 K (-0.64 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 64.45 | 500 | 32,225 | 78,102 | 78.6 K to 78.1 K (-0.64 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 64.36 | 300 | 19,308 | 78,602 | 78.9 K to 78.6 K (-0.38 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 64.34 | 100 | 6,434 | 78,902 | 79 K to 78.9 K (-0.13 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 64.34 | 100 | 6,434 | 79,002 | 79.1 K to 79 K (-0.13 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Sell | S | 64.25 | 500 | 32,125 | 79,102 | 79.6 K to 79.1 K (-0.63 %) |
Jun 10 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Buy | M | 31.97 | 5,000 | 159,850 | 79,602 | 74.6 K to 79.6 K (+6.70 %) |
Mar 04 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Option Exercise | A | 58.58 | 26,100 | 1,528,938 | 26,100 | |
Mar 04 2008 | CRL | CHARLES RIVER LABO ... | ACKERMAN THOMAS F | Corp. Executive VP ... | Grant | A | 0.00 | 5,520 | 0 | 74,602 | 69.1 K to 74.6 K (+7.99 %) |